EDWARDS LIFESCIENCES CORPORATION
NYSE: EW
▼
101.44
-4.02
-3.81%
1 Day
-
Open
105.01
-
Previous Close
105.46
-
Volume (Avg)
185 (2.41M)
-
Day's Range
101.24-105.27
-
52Wk Range
85.58-131.73
-
Market Cap.
62.89B
-
Dividend Rate ( Yield)
-
-
Beta
-
-
Shares Outstanding
-
-
P/E Ratio (EPS)
43.89 (-)
Top Stories
-
Russia is starting to beat Ukraine at electronic warfare, analysts say
The Verge 8/1/2022 -
Edwards Lifesciences is hiring at its ‘key’ Shannon and Limerick facilities
SiliconRepublic -
Insider Selling: Edwards Lifesciences Co. (NYSE:EW) VP Sells 4,811 Shares of Stock
ETF Daily News -
Edwards Lifesciences Co. (NYSE:EW) Shares Sold by Los Angeles Capital Management LLC
Defense World -
StockNews.com Upgrades Edwards Lifesciences (NYSE:EW) to “Buy”
Defense World 3 days ago -
Edwards Lifesciences misses in Q2, lowers guidance
MassDevice -
Edwards Lifesciences Whale Trades Spotted
Benzinga.com -
Edwards Lifesciences (NYSE:EW) Knows How To Allocate Capital
Nasdaq -
Edwards Lifesciences (EW) Q2 Earnings Meet Estimates, Margins Up
Nasdaq -
Citigroup Boosts Edwards Lifesciences (NYSE:EW) Price Target to $118.00
ETF Daily News -
EDWARDS LIFESCIENCES REPORTS SECOND QUARTER RESULTS
YAHOO!Finance -
Edwards Lifesciences Shares Slide As Q2 Results Miss Expectations, Lowers FY22 Sales Outlook
YAHOO!Finance -
Edwards Lifesciences Down Over 6%, On Track for Largest Percent Decrease Since June 2020 — Data Talk
Morningstar%2c Inc. -
Edwards Lifesciences: Q2 Earnings Snapshot
Sacramento Bee -
Edwards Lifesciences Corp. Q2 Profit Decreases, misses estimates
Business Insider 7/28/2022(RTTNews) - Edwards Lifesciences Corp. (EW) revealed a profit for second quarter that decreased from the same period last year and missed the Street estimates. The company's earnings came in at $ ...
-
Analyzing Edwards Lifesciences's Short Interest
Investing -
Medical Devices Market In 2022 : Industry Growth, Top Players, Segmentation and Forecast to 2025 with Top Countries Data | 134 Report Pages
MarketWatch -
Many Would Be Envious Of Edwards Lifesciences' (NYSE:EW) Excellent Returns On Capital
Yahoo Finance